Form 4 for FATE FATE THERAPEUTICS INC
Accepted 2022-07-25 00:00:00 ET · period of report 2022-07-21 · accession 0001209191-22-043143 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-07-25 | 2022-07-21+ | FATE | Wolchko J Scott | Pres, CEO, Dir | S - Sale+OE | $32.74 | -36.2K | 434.9K | -8% | -$1.19M |
| DM | 2022-07-25 | 2022-07-21+ | FATE | Wolchko J Scott | Pres, CEO, Dir | M - OptEx | $2.70 | +36.2K | 437.8K | +9% | +$97.9K |
| DM | 2022-07-25 | 2022-07-21+ | FATE | Wolchko J Scott | Pres, CEO, Dir | M - OptEx | $0.00 | -36.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-22 | S | D | 2,703 | $32.61 | 432,166 | D | — | — | (F5) Represents the weighted average sale price of the shares sold ranging from $32.02 to $33.01 per share. |
| 2 | Common | Common Stock | 2022-07-22 | S | D | 620 | $33.28 | 431,546 | D | — | — | (F6) Represents the weighted average sale price of the shares sold ranging from $33.03 to $33.67 per share. |
| 3 | Common | Common Stock | 2022-07-21 | M | A | 30,000 | $2.70 | 461,546 | D | — | — | |
| 4 | Common | Common Stock | 2022-07-21 | S | D | 19,171 | $33.07 | 431,546 | D | — | — | (F3) Represents the weighted average sale price of the shares sold ranging from $32.83 to $33.33 per share. |
| 5 | Common | Common Stock | 2022-07-21 | S | D | 10,829 | $32.54 | 450,717 | D | — | — | (F2) Represents the weighted average sale price of the shares sold ranging from $31.82 to $32.81 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 6. |
| 6 | Common | Common Stock | 2022-07-22 | S | D | 2,923 | $31.33 | 434,869 | D | — | — | (F4) Represents the weighted average sale price of the shares sold ranging from $30.99 to $31.74 per share. |
| 7 | Common | Common Stock | 2022-07-22 | M | A | 6,246 | $2.70 | 437,792 | D | — | — | |
| 8 | Derivative | Stock Option (Right to Buy) | 2022-07-21 | M | D | 30,000 | $0.00 | 6,246 | D | $2.70 · — to 2027-01-03 | 30,000 Common Stock | (F7) This option is fully vested. |
| 9 | Derivative | Stock Option (Right to Buy) | 2022-07-22 | M | D | 6,246 | $0.00 | 0 | D | $2.70 · — to 2027-01-03 | 6,246 Common Stock | (F7) This option is fully vested. |